ALAFI CAPITAL CO LLC's Net Worth

$291 Million

Estimate Recalculated Sep 8, 2024 07:32PM EST

Who is ALAFI CAPITAL CO LLC?

ALAFI CAPITAL CO LLC has an estimated net worth of $291 Million. This is based on reported shares across multiple companies, which include Stereotaxis, Inc., and Intra-Cellular Therapies, Inc..

SEC CIK

ALAFI CAPITAL CO LLC's CIK is 0001216017

Past Insider Trading and Trends

2014 was ALAFI CAPITAL CO LLC's most active year for acquiring shares with 8 total transactions. ALAFI CAPITAL CO LLC's most active month to acquire stocks was the month of October. 2004 was ALAFI CAPITAL CO LLC's most active year for disposing of shares, totalling 6 transactions. ALAFI CAPITAL CO LLC's most active month to dispose stocks was the month of July. 2017 saw ALAFI CAPITAL CO LLC paying a total of $4,000,007.50 for 258,065 shares, this is the most they've acquired in one year. In 2004 ALAFI CAPITAL CO LLC cashed out on 7,562,806 shares for a total of $0.00, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Stereotaxis, Inc. (STXS) Snapshot price: $2.07

Investor

ALAFI CAPITAL CO LLC owns 2,329,253 units of Common Stock which is worth $4,821,553.71. In the year 2004 ALAFI CAPITAL CO LLC filed a total of 7 filings.

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+0.43%
10K
$10.89
$108,900.00
2.33M
Mar 15
Form 4
+3.43%
76.8K
$7.81
$599,839.24
2.32M
Nov 15
Form 4
+1.05%
23.39K
$7.26
$169,770.02
2.24M
Dec 6
Form 4
+0.39%
8.71K
$7.07
$61,531.48
2.22M
Dec 2 - Dec 5
Form 4
—
0
—
—
0
Nov 28
Form 4
∞
2.21M
—
—
2.21M
Aug 17
Form 3
—
0
—
—
0
No matching records found

Intra-Cellular Therapies, Inc. (ITCI) Snapshot price: $74.25

Investor

ALAFI CAPITAL CO LLC owns 3,953,270 units of Common Stock which is worth $293,530,297.50. In the year 2013 ALAFI CAPITAL CO LLC acquired a total of 410,385 shares in Intra-Cellular Therapies, Inc. at a cost of $6,341,833.61.

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+6.98%
258.06K
$15.50
$4,000,007.50
3.95M
Oct 2
Form 4
+1.79%
65K
$16.27
$1,057,483.27
3.7M
Dec 6 - Dec 7
Form 4
+0.95%
34K
$14.50
$492,969.40
3.63M
Nov 14
Form 4
+0.04%
1.42K
$14.75
$20,974.50
3.6M
Dec 1
Form 4
+0.98%
35K
$14.75
$516,250.00
3.59M
Nov 28
Form 4
+0.03%
1.03K
$14.25
$14,734.50
3.56M
Nov 19
Form 4
+0.10%
3.66K
$14.26
$52,250.44
3.56M
Nov 14 - Nov 18
Form 4
+0.34%
12.2K
$15.34
$187,164.00
3.56M
Nov 11 - Nov 13
Form 3
—
0
—
—
0
No matching records found